Literature DB >> 15891328

NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients.

Antoine Roch1, Jérôme Allardet-Servent, Pierre Michelet, Christiane Oddoze, Jean-Marie Forel, Karine Barrau, Anderson Loundou, Gilles Perrin, Jean-Pierre Auffray, Henri Portugal, Laurent Papazian.   

Abstract

OBJECTIVE: To investigate N-terminal pro-brain natriuretic peptide (NT-proBNP) level as a prognostic factor and a marker of myocardial dysfunction in patients with septic shock.
DESIGN: Prospective observational study.
SETTING: Intensive care unit.
SUBJECTS: A total of 39 patients diagnosed with septic shock and requiring mechanical ventilation.
MEASUREMENTS AND MAIN RESULTS: Demographic, hemodynamic, respiratory, and biological data (notably NT-proBNP, lactate, and cardiac troponin I) were collected at inclusion and every 12 hrs. The independent factors for death were higher Sequential Organ Failure Assessment score in the 24-hr period after inclusion (odds ratio, 4.7; 95% confidence interval, 1.15-19.3) and the highest NT-proBNP level in the 24-hr period after inclusion (odds ratio, 1.12 per 1000 pg/mL increase; 95% confidence interval, 1.05-1.26). An NT-proBNP of >13,600 pg/mL predicted intensive care unit mortality with an accuracy of 77%. Area under the receiver operating characteristic curve was 0.8 (p = .002; 95% confidence interval, 0.66-0.93). NT-proBNP levels were over the accepted normal range in all patients. Values were highest between 24 and 36 hrs after onset of septic shock and were significantly higher in nonsurvivors at each time between inclusion and day 7. The lowest left ventricular stroke work index of the first 24-hr period after inclusion was the only factor that independently influenced higher NT-proBNP levels at the same time (odds ratio, 0.91; 95% confidence interval, 0.84-0.98).
CONCLUSION: NT-proBNP seems to be an early factor of prognosis and myocardial dysfunction in patients with septic shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891328     DOI: 10.1097/01.ccm.0000162561.82012.e9

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

1.  [Sepsis and heart].

Authors:  H Ebelt; K Werdan
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

Review 2.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

3.  Increased levels of pro-AVP and pro-ADM in septic shock patients: what could it mean?

Authors:  Antoine Roch
Journal:  Intensive Care Med       Date:  2009-08-07       Impact factor: 17.440

4.  Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio.

Authors:  Juliana Jensen; Li-Ping Ma; Michael L X Fu; David Svaninger; Per-Arne Lundberg; Ola Hammarsten
Journal:  Clin Res Cardiol       Date:  2010-03-13       Impact factor: 5.460

5.  Diastolic dysfunction and N-terminal pro-brain natriuretic peptide in children with meningococcal sepsis.

Authors:  Fauzia Paize; Niten Makwana; Paul B Baines; Richard Sarginson; Denise J Kitchener; Helen Michaels; Alistair P J Thomson; Sally Eagle; Peter Diggle; C Anthony Hart; Christopher M Parry
Journal:  Intensive Care Med       Date:  2013-05-18       Impact factor: 17.440

6.  The role of endothelium and endogenous vasoactive substances in sepsis.

Authors:  G Kotsovolis; K Kallaras
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

7.  Severity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis.

Authors:  Joachim Wilhelm; Stefan Hettwer; Markus Schuermann; Silke Bagger; Franziska Gerhardt; Sandra Mundt; Susanne Muschik; Julia Zimmermann; Sebastian Bubel; Mroawan Amoury; Thomas Kloess; Rainer Finke; Harald Loppnow; Ursula Mueller-Werdan; Henning Ebelt; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2013-06-06       Impact factor: 5.460

Review 8.  Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?

Authors:  Afif El-Khuffash; Eleanor J Molloy
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-07       Impact factor: 5.747

9.  Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?

Authors:  Ursula Hoffmann; Martina Brueckmann; Martin Borggrefe
Journal:  Crit Care       Date:  2009-12-01       Impact factor: 9.097

10.  The Use of N-Terminal-Pro-BNP in Preterm Infants.

Authors:  Afif El-Khuffash; Eleanor Molloy
Journal:  Int J Pediatr       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.